Amanda Young

Company: Foundation Medicine

Job title: Senior Director - Lifecycle Product Development

Seminars:

Introducing an Improved ctDNA Tumor Fraction Method to Add Value in Translational Research, Clinical Trials & CDx Development 8:30 am

• Discussion on the value of ctDNA monitoring for research and clinical trial programs, including both early- and late-stage disease for MRD and treatment response • Confidence in negative results from a liquid biopsy test, now possible for wild-type biomarkers in trial enrolment • New data on the value of ctDNA tumor fraction in lung,…Read more

day: Day One